Lymphopenia Archives - Critical Care Science (CCS)

  • Original Article09-18-2024

    Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching – Findings from the Multicenter LYMPH-COVID Study

    Critical Care Science. 2024;36:e20240236en

    Abstract

    Original Article

    Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching – Findings from the Multicenter LYMPH-COVID Study

    Critical Care Science. 2024;36:e20240236en

    DOI 10.62675/2965-2774.20240236-en

    Views85

    ABSTRACT

    Objective

    To elucidate the impact of lymphopenia on critical COVID-19 patient outcomes.

    Methods

    We conducted a multicenter prospective cohort study across five hospitals in Portugal and Brazil from 2020 to 2021. The study included adult patients admitted to the intensive care unit with SARS-CoV-2 pneumonia. Patients were categorized into two groups based on their lymphocyte counts within 48 hours of intensive care unit admission: the Lymphopenia Group (lymphocyte serum count < 1 × 109/L) and the Nonlymphopenia Group. Multivariate logistic regression, propensity score matching, Kaplan‒Meier survival curve analysis and Cox proportional hazards regression analysis were used.

    Results

    A total of 912 patients were enrolled, with 191 (20.9%) in the Nonlymphopenia Group and 721 (79.1%) in the Lymphopenia Group. Lymphopenia patients displayed significantly elevated disease severity indices, including Sequential Organ Failure Assessment and Simplified Acute Physiology Score 3 scores, at intensive care unit admission (p = 0.001 and p < 0.001, respectively). Additionally, they presented heightened requirements for vasopressor support (p = 0.045) and prolonged intensive care unit and in-hospital stays (both p < 0.001). Multivariate logistic regression analysis after propensity score matching revealed a significant contribution of lymphopenia to mortality, with an odds ratio of 1,621 (95%CI: 1,275 - 2,048; p < 0.001). Interaction models revealed an increase of 8% in mortality for each decade of longevity in patients with concomitant lymphopenia. In the subanalysis utilizing three-group stratification, the Severe Lymphopenia Group had the highest mortality rate, not only in direct comparisons but also in Kaplan‒Meier survival analysis (log-rank test p = 0.0048).

    Conclusion

    Lymphopenia in COVID-19 patients is associated with increased disease severity and an increased risk of mortality, underscoring the need for prompt support for critically ill high-risk patients. These findings offer important insights into improving patient care strategies for COVID-19 patients.

    See more
    Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching – Findings from the Multicenter LYMPH-COVID Study

Search

Search in:

Article type
article-commentary
brief-report
case-report
correction
editorial
letter
other
rapid-communication
reply
research-article
review-article
Section
Authors' Response
Brief Communication
Case Report
Clinical Information
CLINICAL REPORT
Commentary
Consenso Brasileiro de Monitorização e Suporte Hemodinâmico
Correspondence
Editorial
Erratum
Guidelines and Consensus
III Consenso Brasileiro de Ventilação Mecância
Letter to the Editor
Narrative Review
Original Article
Original Article - Basic Research
Original Article - Clinical Research
Original Article - Neonatology
Original Article - Nursing
Original Article - Pediatrics
Research Letter
Review Article
Review Article - Pediatrics
Série: Medicina baseada em evidências e terapia intensiva
Série: Terminalidade em UTI
Special Article
Terminalidade em UTI pediátrica
Viewpoint
Year / Volume
2025; v.37
2024; v.37
2024; v.36
2023; v.35
2022; v.34
2021; v.33
2020; v.32
2019; v.31
2018; v.30
2017; v.29
2016; v.28
2015; v.27
2014; v.26
2013; v.25
2012; v.24
2011; v.23
2010; v.22
2009; v.21
2008; v.20
2007; v.19
2006; v.18
ISSUE